Who owns the REVENIR trademark?

The REVENIR trademark is owned by Congruence Therapeutics Inc..

What class is the REVENIR trademark registered in?

The REVENIR trademark is registered in Class 042 (Scientific, technology & SaaS services).

What is the serial number for REVENIR?

The USPTO serial number for REVENIR is 79370662.

What is the registration number for REVENIR?

REVENIR is registered under USPTO registration number 7616651.

Sealvo

Home Search: REVENIRREVENIR #79370662

Back

Updated Oct 7, 2026·17 searches this week

View on USPTO TSDR Find similar marks

REV

USPTO Trademark Record

REGISTERED

REVENIR

SN 79370662·Reg 7616651·Filed Mar 15, 2023

Owner Congruence Therapeutics Inc.

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

REVENIR (Serial No. 79370662), Registration No. 7616651, is a registered US trademark filed on Mar 15, 2023 by Congruence Therapeutics Inc.. This trademark covers Class 042 (Scientific, technology & SaaS services).

early section 8: December 24, 2030

Mark Intelligence

REVENIR (Reg. #7616651) is a registered US trademark that has been protecting its owner, Congruence Therapeutics Inc., since 2023. The mark covers Class 042 (Scientific, technology & SaaS services). Goods and services include Scientific and technological services and research and design relating thereto; industrial analysis, industrial research.... The mark faced 4 opposition proceedings during prosecution.

FILED

Mar 15, 2023

SERIAL

79370662

REG#

7616651

REGISTERED

Dec 24, 2024

Filing Information

StatusREGISTERED

Filing DateMar 15, 2023

Serial Number79370662

Registration No.7616651

Registration DateDec 24, 2024

Status DateDec 24, 2024

Published for OppositionNov 05, 2024

Filing Basis & Declarations

Standard Characters Claimed

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 042Scientific, technology & SaaS services

US codes: 100, 101

This description is as filed with the USPTO and defines the scope of trademark protection.

Run a conflict check

Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.

Run conflict check

Status History

38 events

LIMITATION OF GOODS RECEIVED FROM IB

Sep 10, 2026

LIMITATION OF GOODS RECEIVED FROM IB

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Mar 05, 2026

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Mar 05, 2026

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

Mar 05, 2026

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Mar 05, 2026

TEAS CHANGE OF CORRESPONDENCE RECEIVED

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

Mar 05, 2026

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

FINAL DECISION TRANSACTION PROCESSED BY IB

Jun 27, 2025

FINAL DECISION TRANSACTION PROCESSED BY IB

FINAL DISPOSITION NOTICE SENT TO IB

Jun 11, 2025

FINAL DISPOSITION NOTICE SENT TO IB

FINAL DISPOSITION PROCESSED

Jun 10, 2025

FINAL DISPOSITION PROCESSED

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

Mar 24, 2025

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

REGISTERED-PRINCIPAL REGISTER

Dec 24, 2024

REGISTERED-PRINCIPAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Dec 24, 2024

NOTICE OF REGISTRATION CONFIRMATION EMAILED

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

Nov 09, 2024

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

PUBLISHED FOR OPPOSITION

Nov 05, 2024

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Nov 05, 2024

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

Oct 23, 2024

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

Oct 23, 2024

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

NEW REPRESENTATIVE AT IB RECEIVED

Oct 18, 2024

NEW REPRESENTATIVE AT IB RECEIVED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Oct 16, 2024

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Sep 25, 2024

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS/EMAIL CORRESPONDENCE ENTERED

Sep 24, 2024

TEAS/EMAIL CORRESPONDENCE ENTERED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Sep 23, 2024

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Sep 23, 2024

CORRESPONDENCE RECEIVED IN LAW OFFICE

NON-FINAL ACTION WRITTEN

Jul 30, 2024

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Jul 30, 2024

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Jul 30, 2024

NOTIFICATION OF NON-FINAL ACTION E-MAILED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Jul 08, 2024

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Jul 08, 2024

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Jul 08, 2024

TEAS/EMAIL CORRESPONDENCE ENTERED

REFUSAL PROCESSED BY IB

Jan 31, 2024

REFUSAL PROCESSED BY IB

REFUSAL PROCESSED BY MPU

Jan 08, 2024

REFUSAL PROCESSED BY MPU

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

Jan 08, 2024

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

Dec 23, 2023

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

NON-FINAL ACTION WRITTEN

Dec 22, 2023

NON-FINAL ACTION WRITTEN

ASSIGNED TO EXAMINER

Dec 12, 2023

ASSIGNED TO EXAMINER

APPLICATION FILING RECEIPT MAILED

May 30, 2023

APPLICATION FILING RECEIPT MAILED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

May 26, 2023

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

SN ASSIGNED FOR SECT 66A APPL FROM IB

May 25, 2023

SN ASSIGNED FOR SECT 66A APPL FROM IB

Other Marks by Congruence Therapeutics Inc.

Additional USPTO filings from the same owner.

CON

CONGRUENCE

79397307

Congruence Therapeutics Inc.

REGISTERED

CON

CONGRUENCE THERAPEUTICS

90875011

Congruence Therapeutics Inc.

PENDING

Other Marks in Class 042 — Scientific, technology & SaaS services

Recently filed and registered marks in the same international class.

REV

REVENIR ENERGY

97673629

Legacy Reserves Inc.

ABANDONED

Other Marks by Kelsey C. Coplan

Additional USPTO filings handled by the same attorney of record.

XRP

XRPLAY

99458743

REGISTERED

DEL

DELPHY

79422189

87955181

87955204

REVENIR

Run a conflict check

Other Marks by Congruence Therapeutics Inc.

Other Marks in Class 042 — Scientific, technology & SaaS services

Other Marks by Kelsey C. Coplan

Get pre-filing clearance

Search 14M+ trademarks

Resources

Company